What is FRAG(176-191) 5mg
FRAG(176-191) is a synthetic C-terminal fragment of the growth hormone (GH) molecule investigated for its selective activity on adipose tissue signaling and lipid metabolism in controlled laboratory models.
Potential Research Effects
• Lipolysis pathway activation and adipocyte signaling studies
• Exploration of reduced lipogenesis markers in vitro
• Support for fat metabolism and energy utilization research
• Body-composition modeling in preclinical systems
• Glucose handling and insulin-sensitivity pathway exploration
Includes 10 sterile research-use syringes with every vial order.
Cybergen Peptides: Research Use Disclaimer
All products offered by Cybergen Peptides are intended solely for laboratory, educational, and scientific research purposes.
These materials are supplied for in-vitro research only (“in glass”) and are
not intended for human or animal consumption, medical use, or diagnostic applications.
Cybergen Peptides compounds are not drugs, medicines, or dietary supplements and have
not been evaluated or approved by the U.S. Food and Drug Administration (FDA) or any other regulatory agency.
They are not intended to diagnose, treat, cure, or prevent any disease.
Any form of bodily introduction, clinical testing, or therapeutic application is strictly prohibited.
